Home

Aktivität Rund und rund Logik met exon 14 Gehirn Menda City Aktualisieren

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect

The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect
The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer | NEJM
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer | NEJM

MET Mutation Associated with Responsiveness to Crizotinib. - Abstract - Europe PMC
MET Mutation Associated with Responsiveness to Crizotinib. - Abstract - Europe PMC

Mutations as Predictive Biomarkers for Adenocarcinoma | Oncohema Key
Mutations as Predictive Biomarkers for Adenocarcinoma | Oncohema Key

MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values - Journal of Thoracic Oncology
MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values - Journal of Thoracic Oncology

Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews
Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews

Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers - Lung Cancer
Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers - Lung Cancer

PDF] MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life | Semantic Scholar
PDF] MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life | Semantic Scholar

Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study Yu Y, Zhang Q, Zhang J, Lu S - J Can Res Ther
Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study Yu Y, Zhang Q, Zhang J, Lu S - J Can Res Ther

cMET Exon 14 Skipping: From the Structure to the Clinic - ScienceDirect
cMET Exon 14 Skipping: From the Structure to the Clinic - ScienceDirect

The genomic position of METex14 alterations. Genome coordinates are... | Download Scientific Diagram
The genomic position of METex14 alterations. Genome coordinates are... | Download Scientific Diagram

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine

Identification of tumor-specific, intronic mutations in Met leading to... | Download Scientific Diagram
Identification of tumor-specific, intronic mutations in Met leading to... | Download Scientific Diagram

Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations - Journal of Thoracic Oncology
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations - Journal of Thoracic Oncology

MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population
MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population

The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations | NEJM
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations | NEJM

Fragment Analysis Is a More Reliable MET Exon 14 Screening Strate
Fragment Analysis Is a More Reliable MET Exon 14 Screening Strate

Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer
Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer

MET Exon 14 Skipping Mutations in Non-small Cell Lung Cancer]. | Semantic Scholar
MET Exon 14 Skipping Mutations in Non-small Cell Lung Cancer]. | Semantic Scholar

Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer

Lung cancer with MET exon 14 skipping mutation | LCTT
Lung cancer with MET exon 14 skipping mutation | LCTT

Diagnosis and Discussion -- Case 1068
Diagnosis and Discussion -- Case 1068

MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing
MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing